Ketoconazol Kern Pharma

Ketoconazole, the active ingredient in Ketoconazol Kern Pharma, is an imidazole antifungal presented as a topical formulation for skin use. It treats fungal skin infections such as dermatophyte infections, seborrheic dermatitis and pityriasis versicolor in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ketoconazol Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoconazol Kern Pharma is an imidazole antifungal used to manage superficial fungal skin conditions.

Dermatophyte infections (tinea corporis, tinea cruris, tinea pedis): reduces fungal growth and promotes resolution of lesions. Seborrheic dermatitis: alleviates scaling, redness and itching associated with the condition. Pityriasis versicolor: clears skin discoloration by eliminating Malassezia species.

Ketoconazol Kern Pharma may cause local skin reactions.

Common Side Effects: - Itching or pruritus at the application site. - Burning or stinging sensation. - Redness or erythema. - Dryness or flaking of the skin. - Mild irritation or discomfort.

Serious or Rare Side Effects: - Severe allergic reactions such as angioedema or anaphylaxis. - Contact dermatitis with extensive rash. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic toxicity (e.g., liver enzyme elevation) if absorbed in large amounts. - Photosensitivity leading to exaggerated sunburn.

Before using Ketoconazol Kern Pharma, consider the following safety measures.

Pregnancy: safety not established; avoid unless benefits outweigh risks. Breastfeeding: unknown; assess potential risk to infant. Damaged skin: avoid application on open wounds or severely inflamed areas. Concurrent topical antifungals: monitor for increased irritation. Prolonged use: limit duration to the period prescribed by a clinician. Store at room temperature: keep in the original container, protect from moisture and light.

Ketoconazol Kern Pharma can interact with other topical agents and systemic medications.

Major Interactions (Avoid): - Systemic azoles (e.g., itraconazole, fluconazole): risk of additive toxicity if absorbed. - Topical corticosteroids: may reduce antifungal effectiveness. - Alcohol‑based skin products: can increase local irritation.

Moderate Interactions (Monitor Closely): - Other skin irritants (e.g., retinoids): watch for heightened irritation. - Phototoxic agents: monitor for increased photosensitivity. - Hepatotoxic drugs: observe liver function if systemic absorption is suspected.